CANNABIS - AN OVERVIEW

A 2018 assessment of sixteen scientific tests of cannabis-centered medicines for neuropathic suffering, nearly all of which tested a cannabinoid preparation named nabiximols (model name Sativex; a mouth spray made up of both equally THC and CBD that may be authorized in some countries but not in The us), located minimal- to moderate-quality evidenc